Payers
- Health
Drug Makers And Payers To Blame For Biosimilar Barriers In U.S. Market
Biosimilars are gradually gaining traction in the U.S. outpatient drug market, offering a more cost-effective alternative to expensive branded biologics.…
Read More » - Health
What It Means For Patients, Payers, And Pharma
For patients, these shifts in the pharmaceutical landscape can mean uncertainty in access to medications that have been crucial for…
Read More »